Evidence map›Paper›PMID 27546480›Full record

ArticleScientific reports2016

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets.

Ángela Rojas, Jose A Del Campo, Sophie Clement, Matthieu Lemasson, Marta García-Valdecasas, Antonio Gil-Gómez, Isidora Ranchal, Birke Bartosch, Juan D Bautista, Arielle R Rosenberg and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Frontiers in microbiology · 2024
    Review
  5. Article
  6. Recent Advances in Potential Health Benefits of Quercetin.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Bioactive Compounds fromLife (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Review
  19. Functional foods with antiviral activity.Food science and biotechnology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ángela RojasUCM Digestive Diseases, Virgen Macarena-Virgen del Rocío University Hospitals and CIBERehd, Institute of Biomedicine, University of Sevilla, Sevilla, Spain.
Jose A Del CampoUnit for the Clinical Management of Digestive Diseases, Hospital Universitario Valme de Sevilla, Sevilla, Spain.
Sophie ClementDivision of Clinical Pathology, University Hospital, Geneva, Switzerland.
Matthieu LemassonUniversity Paris Descartes, EA 4474 "Hepatitis C Virology", France.
Marta García-ValdecasasUCM Digestive Diseases, Virgen Macarena-Virgen del Rocío University Hospitals and CIBERehd, Institute of Biomedicine, University of Sevilla, Sevilla, Spain.
Antonio Gil-GómezUCM Digestive Diseases, Virgen Macarena-Virgen del Rocío University Hospitals and CIBERehd, Institute of Biomedicine, University of Sevilla, Sevilla, Spain.
Isidora RanchalUnit for the Clinical Management of Digestive Diseases, Hospital Universitario Valme de Sevilla, Sevilla, Spain.
Birke BartoschInserm U1052, Cancer Research Centre, University of Lyon, France DevWeCan Laboratories of Excellence Network (Labex), Lyon, France.
Juan D BautistaBiochemistry and Molecular Biology, Faculty of Pharmacy, University of Sevilla, Spain.
Arielle R RosenbergUniversity Paris Descartes, EA 4474 "Hepatitis C Virology", France.
Francesco NegroDivision of Clinical Pathology, University Hospital, Geneva, Switzerland.
Manuel Romero-GómezUCM Digestive Diseases, Virgen Macarena-Virgen del Rocío University Hospitals and CIBERehd, Institute of Biomedicine, University of Sevilla, Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quercetin is a natural flavonoid, which has been shown to have anti hepatitis C virus (HCV) properties. However, the exact mechanisms whereby quercetin impacts the HCV life cycle are not fully understood. We assessed the effect of quercetin on different steps of the HCV life cycle in Huh-7.5 cells and primary human hepatocytes (PHH) infected with HCVcc. In both cell types, quercetin significantly decreased i) the viral genome replication; ii) the production of infectious HCV particles and iii) the specific infectivity of the newly produced viral particles (by 85% and 92%, Huh7.5 and PHH respectively). In addition, when applied directly on HCV particles, quercetin reduced their infectivity by 65%, suggesting that it affects the virion integrity. Interestingly, the HCV-induced up-regulation of diacylglycerol acyltransferase (DGAT) and the typical localization of the HCV core protein to the surface of lipid droplets, known to be mediated by DGAT, were both prevented by quercetin. In conclusion, quercetin appears to have direct and host-mediated antiviral effects against HCV.

Indexed as

Carcinoma, HepatocellularCell Line, TumorCells, CulturedDiacylglycerol O-AcyltransferaseGene ExpressionHepacivirusHepatocytesHost-Pathogen InteractionsHumansLipid DropletsLiver NeoplasmsQuercetinVirionVirus ReplicationDiacylglycerol O-AcyltransferaseQuercetin

Identifiers

PMID27546480
PMCPMC4992894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.